Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Mar;35(2):174-183.
doi: 10.1111/ppe.12726. Epub 2020 Oct 26.

Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study

Michael S Bloom  1   2 , Neil J Perkins  3 , Lindsey A Sjaarda  3 , Sunni L Mumford  3 , Aijun Ye  3 , Keewan Kim  3 , Daniel L Kuhr  3   4 , Carrie J Nobles  3 , Matthew T Connell  3 , Enrique F Schisterman  3
Affiliations
Randomized Controlled Trial

Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study

Michael S Bloom et al. Paediatr Perinat Epidemiol. 2021 Mar.

Abstract

Background: Obesity, a body mass index (BMI) ≥30 kg/m2 , is linked to infertility, potentially through a greater risk of anovulation due to elevated androgens. Yet, previous studies have not directly assessed the impact of adiposity, or body fat, on anovulation in the absence of clinical infertility.

Objective: To characterise the associations between adiposity and anovulation among women menstruating on a regular basis.

Methods: Women from the EAGeR trial (n = 1200), a randomised controlled trial of low-dose aspirin and pregnancy loss among women trying to conceive, were used to estimate associations between adiposity and incident anovulation. Participants completed baseline questionnaires and anthropometry, and provided blood specimens. Women used fertility monitors for up to six consecutive menstrual cycles, with collection of daily first morning voids for hormone analysis in the first two menstrual cycles for prospective assessment of anovulation. Anovulation was assessed by urine pregnanediol glucuronide or luteinising hormone concentration or the fertility monitor. Weighted mixed-effects log-binomial regression was used to estimate associations between measures of adiposity and incident anovulation, adjusted for free (bioavailable) testosterone, anti-Mullerian hormone (AMH), serum lipids, and demographic and life style factors.

Results: 343 (28.3%) women experienced at least one anovulatory cycle. Anovulation risk was higher per kg/m2 greater BMI (relative risk [RR] 1.03, 95% confidence interval (CI) 1.01, 1.04), cm waist circumference (RR 1.01, 95% CI 1.00, 1.02), mm subscapular skinfold (RR 1.02, 95% CI 1.01, 1.03), and mm middle upper arm circumference (RR 1.04, 95% CI 1.01, 1.06) adjusted for serum free testosterone, AMH, lipids, and other factors.

Conclusions: Adiposity may be associated with anovulation through pathways other than testosterone among regularly menstruating women. This may account in part for reported associations between greater adiposity and infertility among women having menstrual cycles regularly. Understanding the association between adiposity and anovulation might lead to targeted interventions for preventing infertility.

Keywords: adiposity; anovulation; body mass index; female; infertility; obesity; testosterone.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Probability for anovulation associated with BMI (kg/m2)
Figure 2.
Figure 2.
Relative risk (RR) for anovulation associated with a 1 loge difference in serum free testosterone (ng/dL), according to BMI (kg/m2)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Green BB, Weiss NS, Daling JR. Risk of ovulatory infertility in relation to body-weight. Fertility and Sterility. 1988; 50:721–726. - PubMed
    1. Grodstein F, Goldman MB, Cramer DW. Body-mass index and ovulatory infertility. Epidemiology. 1994; 5:247–250. - PubMed
    1. Rich-Edwards JW, Speigelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology. 2002; 13:184–190. - PubMed
    1. Rachon D, Teede H. Ovarian function and obesity-interrelationship, impact on women’s reproductive lifespan and treatment options. Molecular and Cellular Endocrinology. 2010; 316:172–179. - PubMed
    1. Nestler JE. Obesity, insulin, sex steroids and ovulation. International Journal of Obesity. 2000; 24:S71–S73. - PubMed

Publication types